4.7 Article

Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Construction of a novel immune-related prognostic-predicting model of gastric cancer

Ting Pang et al.

Summary: 274 differentially expressed immune-related genes were identified in gastric cancer, and a risk score model and nomogram for predicting prognosis were established. The immune signatures may regulate gastric cancer through inflammation and cell proliferation related pathways.
Article Biochemistry & Molecular Biology

Involvement of CXCL17 and GPR35 in Gastric Cancer Initiation and Progression

Yizhi Li et al.

Summary: The expression of CXCL17 and its receptor GPR35 in different gastric pathological lesions was investigated in this study. The results showed that CXCL17 expression gradually increased during the progression of gastric diseases, but significantly decreased in gastric cancer. GPR35 had a similar expression pattern but remained abundant in gastric cancer. High CXCL17 expression in gastric cancer was associated with less malignant behavior and favorable prognosis. Overexpressing CXCL17 in HGC27 cells upregulated CCL20 expression. In addition, CXCL17 was involved in cancer-promoting pathways and inflammatory activities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, Research & Experimental

Computed tomography-detected extramural venous invasion-related gene signature: a potential negative biomarker of immune checkpoint inhibitor treatment in patients with gastric cancer

Hao Yang et al.

Summary: This study investigates the association between CT-detected EMVI-related genes and immunotherapy resistance and immune escape in gastric cancer patients. The findings suggest that the EMVI gene signature detected by CT could serve as a potential negative biomarker for ICIs treatment, as it is negatively correlated with TMB and MSI, resulting in poorer prognosis. Furthermore, the expression of CXCL12 and SOX17 genes is significantly higher in CT-detected EMVI-positive samples.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Review Biochemistry & Molecular Biology

CXC chemokines influence immune surveillance in immunological disorders: Polycystic ovary syndrome and endometriosis

Amin Ullah et al.

Summary: Reproductive health is particularly important for women during their reproductive age. Female reproductive problems such as polycystic ovary syndrome (PCOS) and endometriosis affect about 10% of women, negatively impacting their health, fertility, and quality of life. CXC chemokines, small chemotactic and secreted cytokines, are found to be dysregulated in both PCOS and endometriosis, playing a critical role in the development and progression of these diseases. Studies have shown that CXC chemokines promote inflammation and are involved in angiogenesis and inflammatory responses. Overexpression of CXC chemokines is associated with poor survival and prognosis. The levels of CXC chemokines significantly impact the circumstances of PCOS and endometriosis patients, indicating their potential as diagnostic and prognostic biomarkers and therapeutic targets. The molecular mechanisms underlying how CXC chemokines promote inflammation and the development of PCOS and endometriosis are currently unknown. This article aims to discuss the functions of CXC chemokines in the promotion, development, and therapy of PCOS and endometriosis, as well as future research directions. The current state and future prospects of CXC chemokine-based therapeutic strategies in managing PCOS and endometriosis are also highlighted.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)

Article Biochemistry & Molecular Biology

circ_0006089 Facilitates Gastric Cancer Progression via Decoying miR- 515-5p and Up-regulating CXCL6

Jing Wang et al.

PROTEIN AND PEPTIDE LETTERS (2023)

Review Endocrinology & Metabolism

A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease

Amin Ullah et al.

Summary: Adipose tissue in obese individuals develops lipids, aberrant adipokines, chemokines, and pro-inflammatory cytokines, leading to low-grade systemic inflammation. This inflammation can result in insulin resistance and metabolic complications like type 2 diabetes and nonalcoholic fatty liver disease. The role of CXC chemokines and chemokine receptors in the development of obesity-related metabolic diseases is still unclear. This review aims to provide an update on the connection between CXC chemokines, obesity, and obesity-related metabolic diseases, exploring their migratory potential, immunomodulatory effects, and potential as a therapeutic predictor.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2023)

Article Gastroenterology & Hepatology

Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma

Jing Chen et al.

Summary: This study provides a detailed analysis of immune cell compositions and states in advanced gastric cancer patients using a single-cell profiling strategy. The findings reveal that gastric signet-ring cell carcinoma (GSRCC) exhibits a quiescent tumor immune microenvironment (TIME), leading to impaired functions of B cells and CD4+ and CD8+ T cells. CXCL13, a central coordinator, plays a crucial role in this transformation. The study also demonstrates that CXCL13 expression can serve as a predictor for the response to immune checkpoint blockade in gastric cancer patients.

GASTROENTEROLOGY (2023)

Article Oncology

Gastric Cancer, Version 2.2022

Jaffer A. Ajani et al.

Summary: Gastric cancer is the third leading cause of cancer-related deaths worldwide, with over 95% being adenocarcinomas. It is often diagnosed at an advanced stage, leading to a poor prognosis. However, systemic therapy can alleviate symptoms, improve survival, and enhance quality of life. The implementation of biomarker testing has significantly impacted clinical practice and patient care. Targeted therapies have shown encouraging results in clinical trials. Palliative management is recommended for patients with unresectable or metastatic cancer.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Article Oncology

Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation

Xingxing Yao et al.

Summary: The study identified 6-phosphofructo-2-kinase (PFKFB3) as a mediator of trastuzumab resistance in HER2-positive gastric cancer, activating the glycolytic pathway. Inhibiting PFKFB3 reduced tumor proliferation and promoted vessel normalization, offering a new strategy for overcoming trastuzumab resistance.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6

Peng Xu et al.

Summary: In this study, circTMC5 was found to be highly expressed in gastric cancer and promoted cancer cell proliferation, invasion, and metastasis by sponging miR-361-3p to up-regulate RABL6 expression, while inhibiting apoptosis. RABL6, highly expressed in gastric cancer, is involved in immune regulation and infiltration.

GASTRIC CANCER (2022)

Article Oncology

Curcumin inhibits the cancer-associated fibroblast-derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway

In-Hye Ham et al.

Summary: This study aimed to investigate the role of the JAK/STAT3 signaling pathway in the chemoresistance of gastric cancer induced by cancer-associated fibroblasts (CAF). The results showed that CAFs increased the resistance of gastric cancer cells to chemotherapy, and this was associated with the activation of the JAK/STAT3 pathway. However, the natural product curcumin was found to inhibit the activation of this pathway and sensitize the cancer cells to chemotherapy. These findings suggest that targeting the JAK/STAT3 pathway may be a potential strategy to overcome chemoresistance in gastric cancer, and curcumin could be a promising natural compound for this purpose.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Article Cell Biology

Characterization of the Prognostic Values of CXCL Family in Epstein-Barr Virus Associated Gastric Cancer

Li Mu et al.

Summary: This study investigated the expression and prognostic value of the CXCL family in EBVaGC. The results demonstrated that elevated expression of CXCL9/10/11/17 mRNA was associated with a better prognosis in EBVaGC patients.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Biotechnology & Applied Microbiology

MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis

Dinuo Li et al.

Summary: This study investigated the impact and mechanism of microRNA (miR)-200b-3p on the viability, migration, and invasion of gastric cancer (GC) cells. The results showed that miR-200b-3p inhibited GC progression by regulating the CXCL12/CXCR7 axis.

BIOENGINEERED (2022)

Article Immunology

The Regulation between CD4(+)CXCR5(+) Follicular Helper T (Tfh) Cells and CD19(+)CD24(hi)CD38(hi) Regulatory B (Breg) Cells in Gastric Cancer

Ying Zhang et al.

Summary: This study investigated the involvement of CXCR5(+)CD4(+) T follicular helper (Tfh) cells and CD19(+)CD24(hi)CD38(hi) regulatory B (Breg) cells in gastric cancer. The results showed that Tfh cells, Breg cells, and CXCL13 levels were significantly increased in gastric cancer patients. Higher levels of Tfh cells were associated with lymphatic metastasis, worse patient outcomes, and increased Breg cells. In vitro coculture experiments demonstrated that B cells could promote Tfh differentiation and CXCL13 expression, while Tfh cells had no significant effect on Breg cell regulation.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Article Oncology

Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5

Jonathan Hernandez et al.

Summary: This article reports a case of aggressive gastric cancer in a young patient, discussing the treatment process and relevant molecular genetic testing results. It suggests that Helicobacter pylori infection and CDH1 gene mutation may be important factors contributing to the increased aggressiveness of the cancer.

CURRENT ONCOLOGY (2022)

Article Medicine, General & Internal

miR-1273h-5p suppresses CXCL12 expression and inhibits gastric cancer cell invasion and metastasis

Yi-Chen Wang et al.

Summary: This study demonstrates that miR-1273h-5p plays a significant role in gastric cancer by regulating cell proliferation, migration, invasion, and apoptosis. Downregulation of miR-1273h-5p leads to upregulation of CXCL12, which may serve as a novel diagnostic and therapeutic target for gastric cancer.

OPEN MEDICINE (2022)

Article Oncology

Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer

Y. Li et al.

Summary: This study investigated the application value of CXCL13 and PECAM-1 in elderly patients with gastric cancer, revealing that these markers are closely related to disease staging, tumor characteristics, and prognosis in elderly patients. High levels of CXCL13 and PECAM-1 were associated with a poorer 5-year overall survival rate, indicating their potential as effective indicators for diagnosis and prognosis in elderly gastric cancer patients.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Article Oncology

RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription

Jianjun Wang et al.

Summary: RP11-323N12.5 is the most up-regulated lncRNA in human gastric cancer, promoting YAP1 transcription by binding to c-MYC within the YAP1 promoter and exhibiting tumor-promoting and immunosuppressive effects. It serves as an ideal therapeutic target in human gastric cancer.

GASTRIC CANCER (2021)

Article Oncology

Identification of a novel immune prognostic model in gastric cancer

Y. Li et al.

Summary: This study developed an immune-related risk model for predicting prognosis and assessing the immune status of gastric cancer patients. The model, based on seven immune-related genes, showed potential in stratifying patients into different risk groups with different prognostic outcomes. Furthermore, the high-risk group exhibited higher levels of immunosuppressive cells and inhibitory immune checkpoints, suggesting a suppressive immune microenvironment in these patients.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Review Oncology

Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy

E. C. Smyth et al.

Summary: Anti-PD-1 therapy has become a new standard of care for selected GEA and ESCC patients, providing significant improvement in efficacy. Comparisons of results from different trials demonstrate the pros and cons of various treatment strategies, which will contribute to the development of personalized therapy in the future.

ANNALS OF ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer

Myung-Giun Noh et al.

Summary: A prediction model has been developed by researchers in South Korea to identify gastric cancer patients who are likely to respond well to immunotherapy based on biomarker data. Signet ring cells and high expression levels of the CXCL11 gene play important roles in predicting patient response to immunotherapy. This study provides crucial insights for selecting suitable candidates for immunotherapy in gastric cancer.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Article Cell Biology

LINC00152 mediates CD8+ T-cell infiltration in gastric cancer through binding to EZH2 and regulating the CXCL9, 10/CXCR3 axis

Jinqing Ou et al.

Summary: The study suggests that inhibition of LINC00152 may suppress tumor progression by promoting CD8(+) T-cell infiltration in gastric cancer.

JOURNAL OF MOLECULAR HISTOLOGY (2021)

Article Oncology

Oncosuppressive role of MicroRNA-205-3p in gastric cancer through inhibition of proliferation and induction of senescence Oncosuppressive role of MicroRNA-205 in gastric cancer

Xiaoyu Ma et al.

Summary: The study reveals that miR-205-3p is down-regulated while CXCL11 is up-regulated in gastric cancer cell lines. By regulating CXCL11, miR-205-3p inhibits Akt activation, reduces proliferation and invasion of GC cells, promotes apoptosis, induces cell senescence, and secretes immunostimulatory SASP factor. Animal experiments confirm that miR-205-3p promotes cell senescence, down-regulates the immunosuppressive signal induced by PD-L1, and recruits more T cells in blood and tumors.

TRANSLATIONAL ONCOLOGY (2021)

Review Microbiology

Eradication of Helicobacter pylori and Gastric Cancer: A Controversial Relationship

Mariagrazia Piscione et al.

Summary: Gastric cancer is the fifth most common cancer worldwide and the third leading cause of death in developed countries, mainly caused by Helicobacter pylori which is considered a type I carcinogen. The development of gastric cancer involves a progression from gastritis to intestinal metaplasia and eventual adenocarcinoma, with steps including chronic non-atrophic gastritis triggered by H. pylori infection.

FRONTIERS IN MICROBIOLOGY (2021)

Article Nutrition & Dietetics

Transcriptome profiling analysis of the response to walnut polyphenol extract in Helicobacter pylori-infected cells

Jong Min Park et al.

Summary: Through RNAseq analysis, it was demonstrated that walnut intake could prevent H. pylori infection and the mode of actions of walnut polyphenol extract. Newly discovered genes enriched with WPE were identified, while inhibitory targets of WPE were also recognized.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2021)

Review Biochemistry & Molecular Biology

Gastritis, Gastric Polyps and Gastric Cancer

Helge Waldum et al.

Summary: Despite a decrease in prevalence over the past few decades, gastric cancer remains a significant global cause of death, with Helicobacter pylori infection reduction being a key factor. The carcinogenic effects of H. pylori are likely due to hypergastrinemia and autoimmune gastritis, while long-term use of proton pump inhibitors may also predispose individuals to ECL cell neoplasia. Additionally, gastric polyps, although generally low in malignant potential, can still pose a cancer risk and share some common risk factors and mechanisms with gastric cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

H. pylori infection induces CXCL8 expression and promotes gastric cancer progress through downregulating KLF4

Zhengxia Liu et al.

Summary: Our study demonstrates that CagA promotes CXCL8 and inhibits KLF4, forming a vicious circle in gastric cancer. CXCL8 acts as a downstream target gene of KLF4, and KLF4 exerts its tumor-suppressive role by suppressing CXCL8.

MOLECULAR CARCINOGENESIS (2021)

Article Pathology

Screening and identification of key genes in EBV-associated gastric carcinoma based on bioinformatics analysis

Hanqing Wang et al.

Summary: This study identified a set of differentially expressed genes between EBV-associated gastric carcinoma and EBV-negative gastric carcinoma, and identified ten hub genes. CXCL11 was selected as a potential biomarker for better prognosis and tumor infiltrating, providing a new perspective on immune therapy for EBV-associated gastric carcinoma.

PATHOLOGY RESEARCH AND PRACTICE (2021)

Article Multidisciplinary Sciences

The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells

Shotaro Nakajima et al.

Summary: Trastuzumab deruxtecan (T-DXd) exhibits an excellent anti-tumor effect through increasing the number of tumor-infiltrating CD8(+) T cells and enhancing major-histocompatibility-complex class I expression in a mouse model. However, its impact on anti-tumor immune responses in human cancers remains largely unknown.

SCIENTIFIC REPORTS (2021)

Article Cell Biology

PLXNC1: A Novel Potential Immune-Related Target for Stomach Adenocarcinoma

Zhizhan Ni et al.

Summary: This study investigated the tumor microenvironment and chronic inflammation in gastric cancer using ATAC-seq, RNA-seq, and survival analysis. PLXNC1 was identified as an immune-related gene significantly associated with M2 macrophages and poor outcome in patients with stomach adenocarcinoma.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-α-B7-H2-dependent pathway in human gastric cancer

Zhi-guo Shan et al.

Summary: The study found increased tumoral neutrophil infiltration in gastric cancer patients as the disease progresses, which is associated with poor patient prognosis. Tumor-derived tumor necrosis factor-alpha promoted neutrophil activation and B7-H2 expression, with significant correlations found between TNF-α levels and CD54(+) or B7-H2(+) neutrophils in tumor tissues.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways

Jing Han et al.

Summary: Abnormal expression of CXCL16 has been shown to be associated with tumor progression and metastasis in various cancers. The high expression of CXCL16 in gastric cancer is related to poor differentiation and pTNM staging, as well as poor survival of patients. Additionally, CXCL16 promotes gastric tumorigenesis by enhancing the ADAM10-dependent CXCL16/CXCR6 axis activation.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Oncology

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+T cells enriched gastric cancer patients

Kaifeng Jin et al.

Summary: High intra-tumoral infiltration of CXCL13(+)CD8(+) T cells predicted poor overall survival and inferior chemotherapeutic responsiveness in gastric cancer. These cells were associated with an immune-evasive contexture characterized by increased regulatory T cells and dysfunctional cytotoxic T lymphocytes. The combinatorial analysis of CXCL13(+)CD8(+) T cell and CD8(+) T cell infiltration stratified patients into distinct risk groups with varying clinical outcomes and responsiveness to chemotherapy. This suggests that intra-tumoral CXCL13(+)CD8(+) T cell infiltration could serve as an independent prognostic and predictive marker for gastric cancer patients.

ONCOIMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies

Julita Machlowska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cell Biology

miR-588 is a prognostic marker in gastric cancer

Yongyi Chen et al.

Aging-US (2020)

Review Biochemistry & Molecular Biology

The Role of Chemokines in the Development of Gastric Cancer-Diagnostic and Therapeutic Implications

Elzbieta Pawluczuk et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Epstein-Barr virus strain variation and cancer

Teru Kanda et al.

CANCER SCIENCE (2019)

Review Medicine, Research & Experimental

The important role played by chemokines influence the clinical outcome of Helicobacter pylori infection

Abdollah Jafarzadeh et al.

LIFE SCIENCES (2019)

Article Oncology

PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin

Won Jung Bae et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Gastroenterology & Hepatology

A Novel Gastric Spheroid Co-culture Model Reveals Chemokine-Dependent Recruitment of Human Dendritic Cells to the Gastric Epithelium

Thomas A. Sebrell et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Biochemistry & Molecular Biology

Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A

Sirjana Shrestha et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Oncology

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer

Chenlu Zhang et al.

BMC CANCER (2018)

Article Biochemistry & Molecular Biology

Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer

Fangfang Chen et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)

Review Biotechnology & Applied Microbiology

The role of selected chemokines and their specific receptors in pancreatic cancer

Marta Lukaszewicz-Zajac et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)

Article Biotechnology & Applied Microbiology

Gastric Cancer Associated Genes Identified by an Integrative Analysis of Gene Expression Data

Bing Jiang et al.

BIOMED RESEARCH INTERNATIONAL (2017)

Article Immunology

Gastric TFF1 Expression from Acute to Chronic Helicobacter Infection

Roberta Esposito et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)

Article Biochemistry & Molecular Biology

DISC1-dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites

Rosalind Norkett et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Medicine, Research & Experimental

CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production

Hongfeng Zhou et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Immunology

Elevated level of some chemokines in plasma of gastric cancer patients

Monika Baj-Krzyworzeka et al.

Central European Journal of Immunology (2016)

Article Oncology

CXCR3A contributes to the invasion and metastasis of gastric cancer cells

Chenggang Yang et al.

ONCOLOGY REPORTS (2016)

Article Gastroenterology & Hepatology

Polarized CD163+tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer

Jae-Young Park et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)

Article Nutrition & Dietetics

Repressed TGF-β signaling through CagA-Smad3 interaction as pathogenic mechanisms of Helicobacter pylori-associated gastritis

Thuy Trang Nguyen et al.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2015)

Review Medicine, Research & Experimental

Immunity, inflammation, and cancer: an eternal fight between good and evil

Shabnam Shalapour et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Gastroenterology & Hepatology

A pro-inflammatory role for Th22 cells in Helicobacter pylori-associated gastritis

Yuan Zhuang et al.

Article Gastroenterology & Hepatology

CXC chemokines and chemokine receptors in gastric cancer: From basic findings towards therapeutic targeting

Hyo Jin Lee et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Preliminary study correlating CX3CL1/CX3CR1 expression with gastric carcinoma and gastric carcinoma perineural invasion

Cheng-Yu Lv et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Helicobacter pylori and interleukin-8 in gastric cancer

Ko Eun Lee et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Review Medical Laboratory Technology

Gastric cancer - The role of matrix metalloproteinases in tumor progression

Marta Lukaszewicz-Zajac et al.

CLINICA CHIMICA ACTA (2011)

Review Biochemistry & Molecular Biology

The expression and role of CXC chemokines in colorectal cancer

Hannelien Verbeke et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2011)

Article Oncology

CXCL5 overexpression is associated with late stage gastric cancer

Jeong Youp Park et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)

Article Pathology

Gene expression profiling in human gastric mucosa infected with Helicobacter pylori

Veronique J. Hofman et al.

MODERN PATHOLOGY (2007)

Article Oncology

Helicobacter pylori-secreting protein Tipα is a potent inducer of chemokine gene expressions in stomach cancer cells

Takashi Kuzuhara et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)

Article Oncology

New tumor necrosis factor-α-inducing protein released from Helicobacter pylori for gastric cancer progression

M Suganuma et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)